Symptoms, Diagnosis, Treatment & Prognosis Guide
Complete guide to valley fever in dogs: early symptoms, diagnostic tests, antifungal treatment options, costs, prognosis by stage.
What Is Valley Fever in Dogs?
Valley fever in dogs is a systemic fungal infection caused by Coccidioides immitis or Coccidioides posadasii — soil-dwelling fungi found predominantly in the arid regions of the southwestern United States, parts of Mexico, and Central/South America. Dogs contract the disease by inhaling fungal spores (arthroconidia) that become airborne when contaminated soil is disturbed through construction, dust storms, digging, or even routine outdoor activity in endemic zones.
According to the Merck Veterinary Manual, approximately 6–10% of dogs living in endemic areas such as Maricopa County, Arizona, and California's San Joaquin Valley will develop clinical valley fever during their lifetime. The disease is not contagious between dogs, from dogs to humans, or between any species — it is acquired exclusively from the environment. Once inhaled, the spores transform into spherules in the lungs, which can remain localized (pulmonary form) or disseminate to bones, joints, eyes, brain, and other organs.
The incubation period typically ranges from 7 to 21 days after spore inhalation, though some dogs may carry a subclinical infection for months before symptoms appear. Young dogs (under 2 years), senior dogs, and immunocompromised animals face the highest risk of dissemination.
Recognizing Valley Fever: Symptoms by Severity
Valley fever symptoms in dogs can mimic dozens of other conditions — from kennel cough to bone cancer — which makes early recognition challenging. The disease presents in two primary forms: pulmonary (confined to the lungs) and disseminated (spread beyond the lungs). Understanding the progression helps you catch warning signs before the infection advances.
Early Warning Signs (Pulmonary Stage)
These symptoms typically appear within 1–3 weeks of spore inhalation and may be mild enough to dismiss as a passing respiratory bug:
| Symptom | What to Watch For | Typical Onset |
|---|---|---|
| Persistent dry cough | Honking or hacking cough lasting more than 7–10 days, often worse after exercise | Week 1–3 |
| Low-grade fever | Temperature between 102.5°F–104°F (39.2°C–40°C), fluctuating | Week 1–2 |
| Lethargy and listlessness | Reduced enthusiasm for walks, increased sleeping, reluctance to play | Week 1–3 |
| Decreased appetite | Eating 50% or less of normal intake for more than 3 consecutive days | Week 2–4 |
| Mild weight loss | 2–5% body weight loss over 2–3 weeks without diet change | Week 3–6 |
Advanced Symptoms (Disseminated Disease)
When the infection spreads beyond the lungs, symptoms become more severe and organ-specific. Disseminated valley fever occurs in roughly 20–30% of symptomatic cases, according to research from the University of Arizona's Valley Fever Center for Excellence.
| Affected System | Symptoms | Severity |
|---|---|---|
| Bones & Joints | Lameness, swollen joints, pain on palpation, reluctance to rise — most commonly affecting long bones (radius, tibia, humerus) | Moderate to Severe |
| Eyes | Uveitis (cloudy or red eye), sudden blindness, squinting, photophobia | Severe |
| Central Nervous System | Seizures, head tilt, circling behavior, behavioral changes, ataxia (uncoordinated movement) | Critical |
| Skin | Draining tracts, non-healing ulcers, subcutaneous abscesses, particularly over bony prominences | Moderate |
| Heart (Pericardium) | Exercise intolerance, fainting episodes, abdominal distension from right-sided heart failure | Critical |
| Kidneys & Liver | Increased thirst and urination, jaundice (yellow gums/eyes), vomiting | Severe |
- Seizures or sudden neurological changes (head tilt, circling, collapse)
- Sudden blindness or severe eye inflammation
- Inability to stand or walk
- Difficulty breathing or rapid, labored respiration
- High fever above 104.5°F (40.3°C) that does not respond to cooling measures
- Complete refusal to eat or drink for more than 24 hours
These signs may indicate disseminated disease or a medical emergency requiring same-day veterinary evaluation.
Risk Factors: Which Dogs Are Most Vulnerable?
Not every dog exposed to Coccidioides spores develops clinical illness. Roughly 60–70% of exposed dogs mount an effective immune response and remain asymptomatic. The following factors significantly increase the risk of active disease and dissemination:
Geographic Exposure
The single greatest risk factor is living in or traveling to endemic regions. In the United States, this includes:
- Arizona: Maricopa, Pima, and Pinal counties (Phoenix and Tucson metro areas) — highest incidence in the country
- California: San Joaquin Valley, Kern County, southern Central Valley, and increasingly, coastal counties as far north as Sacramento
- Nevada: Southern regions including Clark County (Las Vegas area)
- New Mexico: Southern and central regions
- Texas: Western and southern areas, particularly El Paso and the Trans-Pecos region
- Utah: Southwestern corner (Washington County)
Climate change and expanded construction activity have pushed the endemic boundary northward. Cases have been documented in dogs in Washington State and Oregon, areas previously considered non-endemic, according to CDC surveillance data.
Breed and Age Predisposition
While any breed can contract valley fever, veterinary epidemiological data suggests certain patterns:
- Young dogs (6 months to 2 years): Immature immune systems make puppies and adolescents more susceptible to both initial infection and dissemination
- Senior dogs (8+ years): Age-related immune decline increases vulnerability
- Large and giant breeds: Boxers, Cocker Spaniels, and Doberman Pinschers appear overrepresented in disseminated cases, though the genetic mechanism is not fully understood
- Outdoor and working breeds: Pointers, Retrievers, Herding breeds, and any dog that spends significant time digging, sniffing soil, or working in desert terrain faces higher exposure loads
Environmental and Lifestyle Factors
- Dogs with access to large, unlandscaped yards in endemic areas (especially where they dig)
- Recent construction or excavation near the home within the past 30 days
- Dust storm exposure (haboobs in Arizona can carry spore concentrations 10–100x above baseline)
- Dogs that hike off-trail in desert environments
- Immunosuppressed dogs (those on long-term corticosteroids, chemotherapy, or with concurrent illness like Cushing's disease or cancer)
How Veterinarians Diagnose Valley Fever
Because valley fever symptoms overlap with so many other conditions — pneumonia, heartworm disease, lymphoma, bacterial osteomyelitis — diagnosis requires a combination of clinical suspicion (especially in endemic areas), serologic testing, and imaging. Your veterinarian will typically follow a staged diagnostic approach.
Stage 1: Initial Workup
- Complete Blood Count (CBC) & Chemistry Panel: Looks for elevated white blood cell count (particularly monocytes), elevated globulin levels, and possible liver enzyme changes. Cost: $150–$250.
- Coccidioides Serology (Complement Fixation or AGID test): Detects IgM antibodies (early infection marker) and IgG antibodies (later/chronic marker). A positive titer of 1:16 or higher typically confirms active infection, though some dogs with disseminated disease may have very low or paradoxically negative titers. Cost: $75–$150.
- Thoracic Radiographs (Chest X-rays): Reveals characteristic lung lesions — hilar lymphadenopathy (enlarged lymph nodes at the lung root), interstitial or alveolar infiltrates, and possible cavitary lesions. Cost: $200–$400 for 3-view study.
Stage 2: Advanced Diagnostics (If Dissemination Suspected)
- Bone/Joint Radiographs: To identify osteomyelitis (bone infection) — appears as lytic (bone-destroying) lesions, periosteal new bone formation, or joint effusion. Cost: $150–$350 per area.
- Abdominal Ultrasound: Evaluates liver, spleen, kidneys, and abdominal lymph nodes for fungal granulomas. Cost: $350–$600.
- Fine Needle Aspirate or Biopsy: Cytology or histopathology of affected tissue can reveal the characteristic spherules with endospores — definitive proof of infection. Cost: $200–$500 for FNA; $400–$800 for surgical biopsy.
- PCR Testing: Detects Coccidioides DNA in tissue samples. More sensitive than cytology alone but not universally available. Cost: $150–$300.
- Advanced Imaging (CT or MRI): For suspected CNS involvement or complex bone lesions. Cost: $1,200–$3,000 depending on facility.
Total diagnostic cost range: $500–$1,500 for uncomplicated pulmonary cases; $2,000–$5,000+ for suspected disseminated disease requiring advanced imaging and specialist consultation.
Treatment Options for Valley Fever
Valley fever treatment centers on long-term antifungal medication, typically lasting 6–12 months for pulmonary cases and 12–24 months or longer for disseminated disease. The goal is to suppress fungal replication until the dog's immune system can clear or contain the infection.
| Medication | Typical Dose | Duration | Monthly Cost (50 lb / 23 kg dog) | Key Considerations |
|---|---|---|---|---|
| Fluconazole (Diflucane, generic) | 5–10 mg/kg twice daily | 6–12 months (pulmonary); 12–24+ months (disseminated) | $60–$150 (generic) | First-line treatment. Excellent CNS and bone penetration. Well-tolerated. Monitor liver enzymes every 4–8 weeks. |
| Itraconazole (Sporanox, generic) | 5 mg/kg twice daily | 6–12 months | $100–$250 (generic) | Good for bone/joint involvement. Must give with food (fatty meal improves absorption). Higher GI side effect rate. Avoid compounded forms — bioavailability is unreliable. |
| Ketoconazole (Nizoral, generic) | 5–15 mg/kg twice daily | 6–12 months | $30–$80 | Least expensive option but highest side effect profile (vomiting, anorexia, hepatotoxicity). Requires strict twice-daily dosing with food. Less preferred as first-line. |
| Amphotericin B (lipid-complex formulation) | 1–3 mg/kg IV, 2–3 times weekly | 4–8 weeks (induction), then transition to oral azole | $500–$1,500+ per treatment course | Reserved for severe, life-threatening disseminated cases. Requires hospitalization and IV catheter. Nephrotoxic — kidney function monitored before each dose. |
| Nikkomycin Z (investigational) | Per clinical trial protocol | Variable | Not commercially available (as of 2026) | Novel antifungal targeting chitin synthase in Coccidioides. In clinical trials at University of Arizona. May become available within 2–4 years. Promising early results for azole-resistant cases. |
Supportive and Adjunctive Therapies
Antifungal medication is the backbone of treatment, but comprehensive care often includes:
- Anti-inflammatory medication: Short courses of NSAIDs (e.g., carprofen at 2.2 mg/kg twice daily) or corticosteroids for severe inflammatory responses, particularly with bone pain or CNS involvement. Your veterinarian will determine the appropriate agent and dose.
- Cough suppressants: Butorphanol (0.05–0.1 mg/kg) or hydrocodone for persistent, sleep-disrupting cough during the initial treatment phase.
- Appetite stimulants: Mirtazapine (1.875 mg per dog for dogs under 20 lb; 3.75 mg for larger dogs, every 48 hours) or capromorelin (Elura) for dogs with significant anorexia.
- Surgical intervention: Occasionally needed for pericardial effusion (pericardiectomy), large cavitary lung lesions that fail to respond to medication, or to remove infected bone sequestra.
- Nutritional support: Highly palatable, calorie-dense recovery diets (e.g., Hill's a/d, Royal Canin Recovery) to combat weight loss during the initial weeks of treatment.
Prognosis and Life Expectancy
Prognosis for valley fever varies significantly based on disease stage, organ involvement, and response to antifungal therapy. According to the University of Arizona Valley Fever Center for Excellence, the following outcomes are generally expected:
| Disease Stage | Treatment Success Rate | Expected Recovery Timeline | Relapse Risk |
|---|---|---|---|
| Mild Pulmonary (cough, fever, no dissemination) | 90%+ with appropriate antifungal treatment | Clinical improvement in 2–4 weeks; full course 6–9 months | Low (5–10%) if treatment completed and titers return to negative |
| Bone/Joint Disseminated | 70–80% respond to prolonged antifungal therapy | Improvement in 4–8 weeks; treatment 12–24 months minimum | Moderate (20–30%); some dogs require lifelong suppressive therapy |
| Ocular Disseminated | 50–60% retain useful vision with aggressive treatment | Vision prognosis assessed at 4–6 weeks; treatment 12–18+ months | Moderate to High; enucleation may be necessary for blind, painful eyes |
| CNS Disseminated (brain/spinal cord) | 40–50% meaningful response; fluconazole preferred for CNS penetration | Guarded; may require lifelong medication; neurologic deficits may be permanent | High (40%+); seizures may persist even with fungal control |
| Pericardial/Cardiac | 50–60% with combined surgical (pericardiectomy) and medical management | Surgery + 12–24 months antifungal; survival 1–3 years typical | High without surgery; moderate with combined approach |
Life expectancy with successful treatment: Dogs that complete their antifungal course, achieve negative complement fixation titers (below 1:4), and show no signs of dissemination typically go on to live a normal lifespan. Many treated dogs have been documented living 10+ years after recovery.
Relapse management: Approximately 15–20% of all treated dogs experience at least one relapse, typically within 6–12 months of stopping medication. Relapsed cases are retreated with the same or an alternative azole, often for a longer duration. Dogs with multiple relapses may be candidates for lifelong low-dose suppressive fluconazole therapy.
Home Care and Daily Management
Managing a dog with valley fever at home requires consistency, patience, and close attention to subtle changes in behavior and physical condition. Here is a practical daily and weekly framework:
Medication Administration
- Fluconazole and itraconazole should be given at consistent 12-hour intervals. Set phone alarms to prevent missed doses — even one or two skipped doses per week can allow fungal regrowth and promote drug resistance.
- Itraconazole capsules must be given with a full meal containing fat (a tablespoon of canned food, a pat of butter, or a commercial high-fat treat) to ensure absorption. The pellet-form (Sporanox capsules) should not be crushed or opened.
- Use a pill organizer or calendar tracking sheet to document every dose given. Bring this log to recheck appointments.
Monitoring and Recheck Schedule
- Weeks 1–4: Monitor appetite, energy level, cough frequency, and weight daily. Expect gradual improvement but not immediate resolution.
- Week 4–6 recheck: Repeat CBC/chemistry and Coccidioides titer. Your vet will assess whether the current medication is working or if a switch is needed.
- Every 8–12 weeks thereafter: Repeat blood work and titer testing. The goal is a steadily declining complement fixation titer (e.g., from 1:32 → 1:16 → 1:8 → 1:4 → negative).
- Treatment endpoint: Most veterinarians recommend continuing antifungal medication for at least 1–3 months beyond the point where the titer becomes negative and clinical signs have fully resolved.
Lifestyle Adjustments
- Exercise restriction during active treatment: Limit to short, gentle leash walks (10–15 minutes) during the first 4–6 weeks. Avoid running, jumping, and off-leash play, particularly for dogs with bone involvement.
- Dust reduction: Wet down your yard before letting your dog outside during dry months. Avoid areas with recent soil disturbance. Consider keeping your dog indoors during dust storms and high-wind events.
- Indoor air quality: Run HEPA air purifiers in rooms where your dog spends the most time. This benefits recovery and reduces re-exposure to airborne spores.
- Digging prevention: Cover exposed soil with gravel, mulch, or artificial turf. Provide enrichment alternatives (snuffle mats, frozen Kongs, training sessions) to redirect digging instinct.
Cost of Valley Fever Treatment
Treatment costs vary widely depending on disease severity, geographic location, and whether a specialty hospital or general practice manages the case. Here is a realistic breakdown based on 2026 pricing from general practice and specialty veterinary hospitals in endemic states:
| Cost Category | Mild Pulmonary Case | Disseminated Case | Severe/Refractory Case |
|---|---|---|---|
| Initial diagnostics (blood work, X-rays, titer) | $500–$900 | $1,200–$3,000 | $2,500–$5,000+ |
| Antifungal medication (total course) | $400–$1,200 (6–9 months) | $1,000–$4,000 (12–24 months) | $2,000–$8,000+ (24+ months) |
| Recheck blood work and titers (all visits) | $400–$800 | $800–$2,000 | $1,500–$3,500 |
| Supportive medications (pain, appetite, cough) | $50–$200 | $200–$800 | $500–$2,000 |
| Surgery (if needed) | N/A | $2,000–$5,000 | $5,000–$12,000 |
| Hospitalization (Amphotericin B, ICU care) | N/A | $1,500–$4,000 | $3,000–$10,000+ |
| TOTAL ESTIMATED RANGE | $1,350–$3,100 | $6,700–$18,800 | $14,500–$40,500+ |
Pet insurance note: Most comprehensive pet insurance policies cover valley fever diagnosis and treatment as an illness claim, provided the policy was purchased before symptom onset and the waiting period has passed. Annual maximums of $5,000–$10,000 may not fully cover disseminated cases. If you live in an endemic area, consider a policy with unlimited or high annual maximums ($15,000–$30,000).
Prevention: Reducing Your Dog's Risk
There is currently no commercially available vaccine for valley fever in dogs as of 2026, though researchers at the University of Arizona and other institutions have been working on a vaccine candidate. Prevention focuses on exposure reduction:
- Minimize soil disturbance: Avoid letting your dog dig in bare, dry soil. Cover dirt areas with at least 2 inches of gravel, decomposed granite, or artificial turf.
- Wet down dusty areas: Before outdoor play, lightly mist your yard with water to keep soil particles — and spores — from becoming airborne.
- Walk on paved surfaces: In high-risk areas, stick to paved paths and avoid hiking in dusty desert washes, especially during dry, windy months (typically May through October in Arizona).
- Keep windows closed during dust storms: Run air conditioning with clean filters instead of opening windows during haboob events.
- Limit sniffing in construction zones: Active excavation sites can aerosolize massive quantities of spores. Keep your dog on leash and away from any soil-disturbing activity.
- Consider indoor enrichment: On high-dust days, replace outdoor exercise with indoor training games, puzzle feeders, and treadmill walking (for trained dogs).
For dogs that have already recovered from valley fever, re-exposure is still possible. Prior infection does not guarantee lifelong immunity, though most recovered dogs have some degree of residual protection. Continue exposure-reduction practices even after successful treatment.
Frequently Asked Questions
Can humans catch valley fever from their dog?
No. Valley fever is not contagious between species or between individual dogs. Both humans and dogs acquire the infection independently from the same environmental source — inhaling Coccidioides spores from disturbed soil. If your dog is diagnosed with valley fever, it means you share the same environmental risk, and you should discuss any respiratory symptoms you may have with your own physician.
How long does it take for a dog to recover from valley fever?
Most dogs with mild pulmonary valley fever show clinical improvement within 2–4 weeks of starting antifungal medication. However, the full treatment course typically lasts 6–12 months. Disseminated cases require 12–24 months or longer, and some dogs need lifelong suppressive therapy. Never stop medication early, even if your dog seems fully recovered — premature discontinuation is the leading cause of relapse.
Which dog breeds are most prone to valley fever?
While any breed can be affected, Boxers, Cocker Spaniels, and Doberman Pinschers appear overrepresented in disseminated cases. Large-breed, outdoor-active dogs (Pointers, Retrievers, Herding breeds) face higher exposure risk due to their activity patterns. Young dogs under 2 years and seniors over 8 years are more susceptible regardless of breed due to less robust immune function.
Can valley fever in dogs be cured completely?
Yes, in many cases. Dogs with pulmonary valley fever that are diagnosed early and complete their full antifungal course have a 90%+ success rate and typically go on to live normal, healthy lives. Disseminated cases are more challenging — some achieve full remission, while others require ongoing management. The key factors in achieving a cure are early diagnosis, consistent medication administration, and completing the full treatment duration as directed by your veterinarian.
My dog's titer came back negative — does that mean they don't have valley fever?
Not necessarily. False-negative titers occur in approximately 5–15% of confirmed valley fever cases, particularly in dogs with early infection (titers may not rise for 2–4 weeks after symptom onset) or in severely immunocompromised dogs that cannot mount a measurable antibody response. If clinical suspicion remains high based on symptoms, imaging, and geographic exposure, your veterinarian may recommend repeating the titer in 2–3 weeks, pursuing tissue biopsy, or starting empiric antifungal treatment while awaiting further results.
Is valley fever becoming more common in dogs?
Yes. Reported cases in both humans and dogs have increased significantly over the past two decades. Contributing factors include expanded construction in endemic areas, climate-driven drought cycles that increase dust and spore aerosolization, and population growth in the Southwest bringing more dogs into endemic zones. The geographic range of Coccidioides is also expanding, with cases now documented in areas previously considered non-endemic, including parts of Washington State and eastern California.
Should I test my other dogs if one is diagnosed with valley fever?
Testing asymptomatic housemates is generally not recommended, as it rarely changes management. However, if your other dogs share the same exposure history and show any symptoms — even mild cough or lethargy — a screening titer and chest X-rays are reasonable. Discuss with your veterinarian whether proactive screening makes sense for your household's specific risk profile.
Key Takeaways for Dog Owners
Valley fever is a serious but treatable fungal disease that demands early veterinary intervention. If you live in or travel to the southwestern United States with your dog, keep these essentials in mind:
- A persistent cough lasting more than 7–10 days in an endemic-area dog warrants a veterinary visit and Coccidioides titer test.
- Antifungal treatment is a marathon, not a sprint — expect 6–24 months of twice-daily medication with regular blood work monitoring.
- Never stop medication prematurely based on clinical improvement alone; follow your veterinarian's titer-guided protocol.
- Reduce environmental exposure through landscaping modifications, dust control, and avoiding high-risk activities during dry, windy seasons.
- Pet insurance purchased before symptom onset can significantly offset the $1,350–$40,500+ cost range depending on disease severity.
Sources: Merck Veterinary Manual — Coccidioidomycosis in Dogs; University of Arizona Valley Fever Center for Excellence; CDC — Coccidioidomycosis (Valley Fever).
Marcus Aldridge
All our authors care for dogs every day — read more of their work on the authors page.



